Gagnon Advisors, LLC’s Heron Therapeutics Inc Position
Does Gagnon Advisors, LLC own Heron Therapeutics Inc (AXD2)? Not currently — the last reported position was 576.2K shares worth $2M in Q3 2022; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$2M
Q3 2022
Shares
576.2K
% of Portfolio
+1.57%
Quarters Held
1
position exited
Position History AXD2
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2022 | 576.2K | $2M | +1.57% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Gagnon Advisors, LLC’s full portfolio or all institutional holders of AXD2.